Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), and Fibromyalgia.

OMF Founder and CEO/President Linda Tannenbaum sends this update from the ongoing Invest in ME Research Conference Week in London

The conference is going great! Organizers Richard and Pia Simpson planned a phenomenal 2-day science program once again, with over 100 researchers in attendance.

OMF Scientific Advisory Board (SAB) members Ron Davis, Ron Tompkins, Oystein Fluge and Wenzhong Xiao, as well as OMF Science Liaison Chris Armstrong, spoke yesterday. OMF SAB Members Jonas Bergquist and Maureen Hanson are speaking today. Here’s the complete lineup of OMF’s SAB members presenting at the conference:

Ron Davis – Establishing new mechanistic and diagnostic paradigms for ME / CFS

(LtoR) Wenzhong Xiao, Jonas Bergquist, Chris Armstrong, Ron Davis, Ron Tompkins, Oystein Fluge, & Linda Tannenbaum

Ron Tompkins – Harvard Plans for Clinical Research.

Wenzhong Xiao – Severely Ill Patient Study of ME / CFS

Oystein Fluge – Targeted metabolic profiling and associations to clinical data in ME

Maureen Hanson – Extracellular Vesicles in ME / CFS

Jonas Bergquist – Proteomics and autoantibodies

Dan Peterson – (Presentation title TBA)

Our team is thrilled to be participating in such a productive conference, we send our warmest regards to the entire OMF community.

Chris Armstrong & Linda Tannenbaum, IiME 2019 London

Stay Informed

Be the first to hear our research news.

Subscribe Now.

No thanks